NCT05365282

Brief Summary

Evaluation of potential nerve damage after radial CAG/PCI.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
31mo left

Started Jan 2024

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Jan 2024Dec 2028

First Submitted

Initial submission to the registry

May 4, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 9, 2022

Completed
1.6 years until next milestone

Study Start

First participant enrolled

January 1, 2024

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2028

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2028

Last Updated

April 23, 2026

Status Verified

April 1, 2026

Enrollment Period

4.2 years

First QC Date

May 4, 2022

Last Update Submit

April 22, 2026

Conditions

Keywords

Transradial accessIschemic Heart DiseaseHand Dysfunction

Outcome Measures

Primary Outcomes (1)

  • Neurophysiological measurements

    The primary aim is the incidence/presence of electrofysiological signs of median and/or ulnar nerve lesion at the wrist and the presence of carpaltunnel syndrom. The electrodiagnosis of carpaltunnelsyndrom will be determined from the clinical picture and signs of prolonged distal motor lantency and reduced motor and sensory nerveconduction velocity across the wrist and/or reduced amplitudes of the median nerve and normal ulnar nerve at the wrist.

    Aprox 1 hour

Secondary Outcomes (2)

  • Severity of hand symptoms and hand dysfunction

    10min

  • Severity of hand symptoms and hand dysfunction

    10 min

Study Arms (2)

Group A

Access pathway a. radialis (right or left) and neurophysiological measurements of the same hand (ipsilateral intervention group).

Group B

Access pathway a.radialis (right or left) and neurophysiological measurements of opposite hand (contralateral intervention group).

Eligibility Criteria

Age18 Years+
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients suspected of ischemic heart disease scheduled for radial CAG/PCI at Aarhus University Hospital

You may qualify if:

  • The patient must be able to give informed consent

You may not qualify if:

  • Pregnancy
  • Negative Barbeau test

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of cardiology, Aarhus University Hospital in Skejby

Aarhus, 8200, Denmark

RECRUITING

MeSH Terms

Conditions

Myocardial IschemiaCarpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesVascular DiseasesMedian NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries

Study Officials

  • Christian J Terkelsen, Professor

    Aarhus University Hospital

    STUDY CHAIR

Central Study Contacts

Christel G Aagren Nielsen

CONTACT

Christian J Terkelsen, Professor

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Professor, Chief Physician, PhD.

Study Record Dates

First Submitted

May 4, 2022

First Posted

May 9, 2022

Study Start

January 1, 2024

Primary Completion (Estimated)

March 1, 2028

Study Completion (Estimated)

December 1, 2028

Last Updated

April 23, 2026

Record last verified: 2026-04

Locations